Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION - Additional Information (Detail)

v3.22.1
STOCK-BASED COMPENSATION - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 23, 2022
Mar. 31, 2022
Mar. 31, 2021
Mar. 21, 2022
Feb. 09, 2022
Stockholders Equity Note [Line Items]          
Stock compensation expense   $ 386 $ 315    
Impairment charges on property plant and equipment   0 24    
Accumulated Net Investment Gain (Loss) Attributable to Parent          
Stockholders Equity Note [Line Items]          
Reclassification to earnings, tax effect   0 0    
Accumulated Defined Benefit Plans Adjustment Attributable to Parent          
Stockholders Equity Note [Line Items]          
Net actuarial gain (loss) resulting from remeasurements of plan assets and liabilities (net of tax effect of $11 and $1,544)   31 4,901    
Reclassification to earnings (net of tax effect of and )   (7) (2,475)    
Net actuarial gain (loss) resulting from remeasurements of plan assets and liabilities, tax effect   $ 11 $ 1,544    
Management Incentive Award          
Stockholders Equity Note [Line Items]          
Closing New York Stock Exchange price         $ 225.07
Management Incentive Award | International employee          
Stockholders Equity Note [Line Items]          
Closing New York Stock Exchange price       $ 218.56  
Long-Term Incentive Performance Award          
Stockholders Equity Note [Line Items]          
Award vesting period   3 years      
Long-Term Incentive Performance Award | Restricted Units | Year 2021          
Stockholders Equity Note [Line Items]          
Weighted-average fair value of options granted (usd per share) $ 230.67        
Nonqualified Stock Options          
Stockholders Equity Note [Line Items]          
Award vesting period   5 years      
Percentage of the award vesting at each anniversary date of the grant   20.00%      
Expiration period (in years)   10 years      
Stock options granted   100,000      
Weighted-average fair value of options granted (usd per share) $ 214.58